Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

The Amazon-Berkshire-JPMorgan Chase Healthcare Venture Disbands

By Brian Orelli, PhD - Jan 4, 2021 at 3:14PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Improving healthcare is hard, even for top-notch companies.

Smart people from three very successful companies -- Amazon ( AMZN 1.11% ), Berkshire Hathaway ( BRK.A 1.80% ) ( BRK.B 1.42% ), and JPMorgan Chase ( JPM 1.18% ) -- apparently couldn't figure out how to make the U.S. healthcare system more efficient. The companies' joint venture, Haven, is disbanding, according to a report by CNBC.

When they came together three years ago, Warren Buffett of Berkshire Hathaway, Jeff Bezos of Amazon, and Jamie Dimon of JPMorgan Chase were initially looking to reduce the healthcare costs for their employees. If Haven was successful, the undertone was that the entity could offer services that ring out inefficiencies in the system to other companies that eventually wanted to sign up. The plan was for Haven to not turn a profit, allowing most of the financial benefits to be passed along.

Pills and capsules randomly placed on $100 bills.

Image source: Getty Images.

A spokeswoman for Haven told CNBC that the companies would still work informally together on ways to improve healthcare efficiencies based on what Haven had learned. Many of Haven's 57 employees are apparently being offered jobs at the three companies.

We don't know exactly why Haven was shuttered, but it seems likely the group couldn't find enough efficiencies to justify the cost of the organization. While it was an ambitious idea for the healthcare outsiders, falling short of the goal isn't particularly surprising considering health insurers have been working for years to lower costs.

For example, to negotiate lower costs, payers need to be able to walk away if they can't get a low enough price. Excluding high-priced products and services works fine when there are multiple competing drugs, devices, or providers that insurers can pit against each other. But when healthcare companies have a monopoly and won't budge on price, payers unwilling to exclude options for their employees have no choice but to pay the higher cost.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned, Inc. Stock Quote, Inc.
$3,427.37 (1.11%) $37.58
Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
$426,200.00 (1.80%) $7,524.00
Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
$281.38 (1.42%) $3.95
JPMorgan Chase & Co. Stock Quote
JPMorgan Chase & Co.
$160.16 (1.18%) $1.87

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/07/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.